Changyu Wu Selected Research

ferrocene

3/2013	Synergistic antibacterial activity of new isomeric carborane derivatives through combination with nanoscaled titania.
1/2013	Antimicrobial activity of a ferrocene-substituted carborane derivative targeting multidrug-resistant infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Changyu Wu Research Topics

Disease

4	Neoplasms (Cancer) 12/2021 - 02/2015
1	Rheumatoid Arthritis 06/2022
1	Breast Neoplasms (Breast Cancer) 08/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Leukemia 02/2015
1	Cross Infection (Nosocomial Infection) 03/2013
1	Infections 01/2013
1	Bacterial Infections (Bacterial Infection) 01/2013

Drug/Important Bio-Agent (IBA)

2	ferroceneIBA 03/2013 - 01/2013
1	Polysaccharides (Glycans)IBA 06/2022
1	AGRO 100IBA 08/2021
1	dextran-bound sulfonamideIBA 08/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	C-Reactive ProteinIBA 01/2021
1	human AZU1 proteinIBA 01/2021
1	3- (4,5- dimethyl- 2- thiazolyl)- 2,5- diphenyl- 2H- tetrazolium bromideIBA 11/2015
1	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2015
1	SolutionsIBA 11/2015
1	Molecular Probes (Molecular Probe)IBA 02/2015
1	titanium dioxide (Titania)FDA Link 03/2013

Therapy/Procedure

3	Therapeutics 12/2021 - 01/2021
1	Precision Medicine 12/2021
1	Photothermal Therapy 08/2021
1	Aftercare (After-Treatment) 11/2015